0001140361-16-065518.txt : 20160516 0001140361-16-065518.hdr.sgml : 20160516 20160516141502 ACCESSION NUMBER: 0001140361-16-065518 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160516 DATE AS OF CHANGE: 20160516 EFFECTIVENESS DATE: 20160516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: eXIthera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001554842 IRS NUMBER: 460548420 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-223015 FILM NUMBER: 161652676 BUSINESS ADDRESS: STREET 1: 1900 WEST PARK DRIVE SUITE 280 CITY: WESTBOROUGH STATE: MA ZIP: 01581 BUSINESS PHONE: 617-852-1960 MAIL ADDRESS: STREET 1: 1900 WEST PARK DRIVE SUITE 280 CITY: WESTBOROUGH STATE: MA ZIP: 01581 FORMER COMPANY: FORMER CONFORMED NAME: eXIthera Pharmaceuticals LLC DATE OF NAME CHANGE: 20120724 FORMER COMPANY: FORMER CONFORMED NAME: eXlthera Pharmaceuticals LLC DATE OF NAME CHANGE: 20120724 D/A 1 primary_doc.xml X0707 D/A LIVE 0001554842 eXIthera Pharmaceuticals, Inc. 1900 WEST PARK DRIVE &nbspSUITE 280 WESTBOROUGH MA MASSACHUSETTS 01581 617-852-1960 DELAWARE None eXIthera Pharmaceuticals LLC eXlthera Pharmaceuticals LLC Corporation true 2012 Neil J. Hayward 1900 West Park Drive Suite 280 Westborough MA MASSACHUSETTS 01581 Executive Officer Director Chief Executive Officer of the Issuer. William Koster 1900 West Park Drive Suite 280 Westborough MA MASSACHUSETTS 01581 Director Frans Stassen 1900 West Park Drive Suite 280 Westborough MA MASSACHUSETTS 01581 Director Isaac Kohlberg 1900 West Park Drive Suite 280 Westborough MA MASSACHUSETTS 01581 Director Fred Meyer 1900 West Park Drive Suite 280 Westborough MA MASSACHUSETTS 01581 Director Scott Yaphe 1900 West Park Drive Suite 280 Westborough MA MASSACHUSETTS 01581 Director Biotechnology Decline to Disclose 06b true 0001140361-14-033074 2014-08-04 false true true Series B Preferred Stock false 0 10000000 10000000 0 false 2 0 0 0 false eXIthera Pharmaceuticals, Inc. /s/ Neil J. Hayward Neil J. Hayward Chief Executive Officer of the Issuer 2016-05-16